(Q73156200)

English

Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease

scientific article published on 01 October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pier Maria Battezzati

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Maria Rita Castellani

1 reference

ORCID Public Data File 2021

author name string

C Colombo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Crosignani

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M R Castellani

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Comi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M L Melzi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Giunta

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

672-677

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

The changing epidemiology of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver and biliary problems in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver disease and common-bile-duct stenosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver disease and bile duct abnormalities in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of hepatobiliary scintigraphy in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The ursodeoxycholic acid story in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenosine triphosphate activates ion permeabilities in biliary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatoprotective properties of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular aspects of membrane stabilization by ursodeoxycholate [see comment]

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980347-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(99)80347-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10551391%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73156200&oldid=1900008720"